TheraBionic P1 Device in Subjects With Advanced Hepatocellular Carcinoma

This study is testing the TheraBionic P1 device — a wearable that delivers very low-level radiofrequency electromagnetic fields — in patients with advanced liver cancer (hepatocellular carcinoma, or HCC) who have already tried multiple treatments. The device is non-invasive and can be used by people with pacemakers or other implants. **You may be eligible if...** - You have advanced liver cancer (HCC) that cannot be treated with local therapies, or that came back after such treatment - You have already tried at least two standard treatment options, or you are no longer able to tolerate further standard therapy - You are in acceptable general health with reasonable organ function **You may NOT be eligible if...** - You have not yet tried available standard treatments - Your liver or overall health function is severely compromised - You are pregnant or breastfeeding - You are unwilling to follow study procedures Talk to your doctor to see if this trial is right for you.